特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

PDXモデルの世界市場:業界動向と2027年までの予測

Global PDX Models Market - Industry Trends and Forecast to 2027

発行 Data Bridge Market Research Private Limited 商品コード 942336
出版日 ページ情報 英文 328 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=107.13円で換算しております。
PDXモデルの世界市場:業界動向と2027年までの予測 Global PDX Models Market - Industry Trends and Forecast to 2027
出版日: 2020年05月01日 ページ情報: 英文 328 Pages
概要

世界のPDXモデル市場は、2020年から2027年の予測期間中に16.6%のCAGRで堅実に成長すると予測されています。当レポートには、2018年の実績データが含まれ、計算の基準年は2019年、予測期間は2020年から2027年です。

世界の PDXモデル市場の主な成長促進要因

前臨床調査におけるPDXモデルの幅広い採用

オーダーメイド医療の需要の増加

政府および民間組織による戦略的イニシアチブ

当レポートでは、世界のPDXモデル市場について調査し、市場概要、セグメント別の市場分析、地域別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 市場セグメンテーション

第3章 エグゼクティブサマリー

第4章 重要考察

  • 潜在的な代替アプローチと置換分析

第5章 市場概要

  • 促進要因
    • 前臨床調査におけるPDXモデルの幅広い採用
    • オーダーメイド医療に対する需要の増加
    • ヒト化PDXモデル需要の増加
    • 癌研究のための開発業務受託機関(CROS)や学術調査機関
  • 抑制要因
    • 動物の利用に関する倫理的問題
    • カスタマイズされたPDXモデルの高コスト
  • 市場機会
    • 製薬業界における研究開発活動の増加
    • 政府および民間セクターによる戦略的イニシアチブ
  • 課題
    • 癌研究における動物モデルの使用に関する厳格なガイドライン
    • PDXモデルの制約

第6章 SARS-COV-2パンデミックによる影響の分析

第7章 世界の PDXモデル市場、タイプ別

  • 概要
  • マウスモデル
    • 基本的な癌研究
    • 前臨床薬の開発
    • バイオマーカー分析
    • 共同臨床試験
    • 精密医療
  • ラットモデル
    • 基本的な癌研究
    • 前臨床薬の開発
    • バイオマーカー分析
    • 共同臨床試験
    • 精密医療

第8章 世界の PDXモデル市場、腫瘍タイプ別

  • 概要
  • 胃腸腫瘍モデル
    • 結腸直腸腫瘍
    • 膵臓腫瘍
    • 肝腫瘍
    • その他
  • 肺腫瘍モデル
    • 扁平上皮癌
    • 大細胞癌
    • 腺癌
    • 気管支腫瘍
  • 血液腫瘍モデル
    • リンパ腫
    • 白血病
  • 婦人科腫瘍モデル
    • 卵巣腫瘍
    • 乳房腫瘍
    • 子宮頸部腫瘍
  • 呼吸器腫瘍モデル
  • 泌尿器腫瘍モデル
    • 膀胱腫瘍
    • 前立腺腫瘍
    • 腎腫瘍
  • その他

第9章 世界の PDXモデル市場、アプリケーション別

  • 概要
  • 基本的な癌研究
    • 癌生物学の特性評価
    • 腫瘍形成
    • 転移
  • 前臨床薬の開発
  • バイオマーカー分析
  • 共同臨床試験
  • 精密医療

第10章 世界の PDXモデルの市場、技術別

  • 概要
  • 異所移植
  • 同所移植

第11章 世界の PDXモデル市場、エンドユーザー別

  • 概要
  • 学術調査機関
  • 開発業務受託機関
  • 製薬およびバイオテクノロジー企業
  • その他

第12章 世界の PDXモデル市場、 地域別

  • 概要
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • スイス
    • オランダ
    • ベルギー
    • ロシア
    • トルコ
    • その他欧州
  • アジア太平洋地域
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • インド
    • シンガポール
    • インドネシア
    • マレーシア
    • タイ
    • フィリピン
    • その他アジア太平洋地域
  • 南米
    • ブラジル
    • アルゼンチン
    • 南米
  • 中東・アフリカ
    • 南アフリカ
    • アラブ首長国連邦
    • イスラエル
    • サウジアラビア
    • エジプト
    • その他中東・アフリカ

第13章 世界の PDXモデル市場、企業情勢

  • 企業シェア分析: 世界の
  • 企業シェア分析: 北米
  • 企業シェア分析:欧州
  • 企業シェア分析:アジア太平洋地域

第14章 SWOT分析: 世界の PDXモデル市場

  • SWOT分析
    • 強み:幅広い製品ポートフォリオ
    • 強み:広範な研究開発発活動
    • 弱点:高コスト
    • 市場機会:子会社を通じた事業拡大
    • 市場機会:戦略的イニシアチブ(特にコラボレーション)
    • 脅威:癌研究用動物モデルの使用に関する厳格なガイドライン
  • DATA BRIDGE 調査分析: 世界の PDXモデル市場

第15章 企業プロファイル

  • CROWN BIOSCIENCE INC.
  • THE JACKSON LABORATORY
  • CHAMPIONS ONCOLOGY, INC.
  • CHARLES RIVER LABORATORIES
  • WUXI APPTEC
  • ONCODESIGN
  • ARAGEN BIOSCIENCE
  • BIOCYTOGEN
  • BIODURO
  • BIOMODELS
  • CREATIVE ANIMODEL
  • COVANCE INC.
  • EPO BERLIN-BUCH GMBH
  • EUROPDX.
  • EXPLORA BIOLABS
  • HERA BIOLABS
  • HORIZON DISCOVERY LTD.
  • PHARMATEST SERVICES
  • UROSPHERE SAS
  • XENTECH
  • XENOPAT

第16章 アンケート調査

第17章 関連レポート

図表

LIST OF TABLES

  • TABLE 1 HOST MOUSE STRAINS USED BY INSTITUTION
  • TABLE 2 PDX MODELS USED TO EVALUATE VARIOUS NEW DRUGS & TARGET
  • TABLE 3 PDX MODELS USED FOR PANCREATIC CANCER WITH INCREASE IN SUCCESSION RATE
  • TABLE 4 PDX SERVICE
  • TABLE 5 PDX TAKE-RATE FROM TUMOUR TISSUE IMPLANTATIONS
  • TABLE 6 CANCER TECHNOLOGY PROJECT AWARDED CANCER MOONSHOT FUNDING
  • TABLE 7 GLOBAL PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 8 GLOBAL PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 9 GLOBAL MICE MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 10 GLOBAL MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 11 GLOBAL RAT MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 12 GLOBAL RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 13 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 14 GLOBAL GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 15 GLOBAL GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 16 GLOBAL LUNG TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 17 GLOBAL LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 18 GLOBAL HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 19 GLOBAL HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 20 GLOBAL GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 21 GLOBAL GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 22 GLOBAL RESPIRATORY TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 23 GLOBAL UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 24 GLOBAL UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 25 GLOBAL OTHERS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 26 GLOBAL PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 27 GLOBAL BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 28 GLOBAL BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 29 GLOBAL PRECLINICAL DRUG DEVELOPMENT IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 30 GLOBAL BIOMARKER ANALYSIS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 31 GLOBAL CO-CLINICAL TRIALS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 32 GLOBAL PRECISION MEDICINE IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 33 GLOBAL PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 34 GLOBAL HETEROTOPIC IMPLANTATION IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 35 GLOBAL ORTHOTOPIC IMPLANTATION IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 36 GLOBAL PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 37 GLOBAL ACADEMIC AND RESEARCH INSTITUTIONS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 38 GLOBAL CONTRACT RESEARCH ORGANIZATIONS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 39 GLOBAL PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 40 GLOBAL OTHERS IN PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 41 GLOBAL PDX MODELS MARKET, BY REGION, 2018-2027 (USD THOUSAND)
  • TABLE 42 NORTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 43 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 44 NORTH AMERICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 45 NORTH AMERICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 46 NORTH AMERICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 47 NORTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 48 NORTH AMERICA GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 49 NORTH AMERICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 50 NORTH AMERICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 51 NORTH AMERICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 52 NORTH AMERICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 53 NORTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 54 NORTH AMERICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 55 NORTH AMERICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 56 NORTH AMERICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 57 U.S. PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 58 U.S. PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 59 U.S. MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 60 U.S. RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 61 U.S. PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 62 U.S. GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 63 U.S. GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 64 U.S. LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 65 U.S. HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 66 U.S. UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 67 U.S. PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 68 U.S. BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 69 U.S. PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 70 U.S. PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 71 CANADA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 72 CANADA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 73 CANADA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 74 CANADA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 75 CANADA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 76 CANADA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 77 CANADA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 78 CANADA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 79 CANADA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 80 CANADA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 81 CANADA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 82 CANADA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 83 CANADA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 84 CANADA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 85 MEXICO PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 86 MEXICO PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 87 MEXICO MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 88 MEXICO RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 89 MEXICO PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 90 MEXICO GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 91 MEXICO GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 92 MEXICO LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 93 MEXICO HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 94 MEXICO UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 95 MEXICO PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 96 MEXICO BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 97 MEXICO PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 98 MEXICO PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 99 EUROPE PDX MODELS MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 100 EUROPE PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 101 EUROPE PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 102 EUROPE MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 103 EUROPE RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 104 EUROPE PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 105 EUROPE GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 106 EUROPE GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 107 EUROPE LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 108 EUROPE HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 109 EUROPE UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 110 EUROPE PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 111 EUROPE BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 112 EUROPE PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 113 EUROPE PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 114 GERMANY PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 115 GERMANY PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 116 GERMANY MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 117 GERMANY RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 118 GERMANY PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 119 GERMANY GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 120 GERMANY GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 121 GERMANY LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 122 GERMANY HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 123 GERMANY UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 124 GERMANY PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 125 GERMANY BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 126 GERMANY PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 127 GERMANY PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 128 FRANCE PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 129 FRANCE PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 130 FRANCE MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 131 FRANCE RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 132 FRANCE PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 133 FRANCE GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 134 FRANCE GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 135 FRANCE LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 136 FRANCE HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 137 FRANCE UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 138 FRANCE PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 139 FRANCE BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 140 FRANCE PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 141 FRANCE PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 142 U.K. PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 143 U.K. PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 144 U.K. MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 145 U.K. RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 146 U.K. PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 147 U.K. GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 148 U.K. GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 149 U.K. LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 150 U.K. HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 151 U.K. UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 152 U.K. PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 153 U.K. BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 154 U.K. PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 155 U.K. PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 156 ITALY PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 157 ITALY PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 158 ITALY MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 159 ITALY RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 160 ITALY PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 161 ITALY GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 162 ITALY GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 163 ITALY LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 164 ITALY HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 165 ITALY UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 166 ITALY PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 167 ITALY BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 168 ITALY PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 169 ITALY PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 170 SPAIN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 171 SPAIN PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 172 SPAIN MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 173 SPAIN RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 174 SPAIN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 175 SPAIN GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 176 SPAIN GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 177 SPAIN LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 178 SPAIN HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 179 SPAIN UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 180 SPAIN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 181 SPAIN BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 182 SPAIN PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 183 SPAIN PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 184 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 185 SWITZERLAND PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 186 SWITZERLAND MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 187 SWITZERLAND RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 188 SWITZERLAND PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 189 SWITZERLAND GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 190 SWITZERLAND GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 191 SWITZERLAND LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 192 SWITZERLAND HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 193 SWITZERLAND UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 194 SWITZERLAND PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 195 SWITZERLAND BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 196 SWITZERLAND PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 197 SWITZERLAND PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 198 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 199 NETHERLANDS PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 200 NETHERLANDS MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 201 NETHERLANDS RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 202 NETHERLANDS PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 203 NETHERLANDS GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 204 NETHERLANDS GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 205 NETHERLANDS LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 206 NETHERLANDS HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 207 NETHERLANDS UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 208 NETHERLANDS PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 209 NETHERLANDS BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 210 NETHERLANDS PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 211 NETHERLANDS PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 212 BELGIUM PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 213 BELGIUM PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 214 BELGIUM MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 215 BELGIUM RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 216 BELGIUM PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 217 BELGIUM GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 218 BELGIUM GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 219 BELGIUM LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 220 BELGIUM HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 221 BELGIUM UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 222 BELGIUM PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 223 BELGIUM BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 224 BELGIUM PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 225 BELGIUM PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 226 RUSSIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 227 RUSSIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 228 RUSSIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 229 RUSSIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 230 RUSSIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 231 RUSSIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 232 RUSSIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 233 RUSSIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 234 RUSSIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 235 RUSSIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 236 RUSSIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 237 RUSSIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 238 RUSSIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 239 RUSSIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 240 TURKEY PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 241 TURKEY PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 242 TURKEY MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 243 TURKEY RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 244 TURKEY PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 245 TURKEY GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 246 TURKEY GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 247 TURKEY LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 248 TURKEY HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 249 TURKEY UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 250 TURKEY PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 251 TURKEY BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 252 TURKEY PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 253 TURKEY PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 254 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 255 REST OF EUROPE PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 256 ASIA-PACIFIC PDX MODELS MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 257 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 258 ASIA-PACIFIC PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 259 ASIA-PACIFIC MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 260 ASIA-PACIFIC RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 261 ASIA-PACIFIC PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 262 ASIA-PACIFIC GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 263 ASIA-PACIFIC GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 264 ASIA-PACIFIC LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 265 ASIA-PACIFIC HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 266 ASIA-PACIFIC UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 267 ASIA-PACIFIC PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 268 ASIA-PACIFIC BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 269 ASIA-PACIFIC PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 270 ASIA-PACIFIC PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 271 CHINA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 272 CHINA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 273 CHINA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 274 CHINA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 275 CHINA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 276 CHINA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 277 CHINA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 278 CHINA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 279 CHINA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 280 CHINA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 281 CHINA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 282 CHINA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 283 CHINA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 284 CHINA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 285 JAPAN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 286 JAPAN PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 287 JAPAN MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 288 JAPAN RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 289 JAPAN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 290 JAPAN GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 291 JAPAN GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 292 JAPAN LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 293 JAPAN HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 294 JAPAN UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 295 JAPAN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 296 JAPAN BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 297 JAPAN PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 298 JAPAN PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 299 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 300 SOUTH KOREA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 301 SOUTH KOREA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 302 SOUTH KOREA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 303 SOUTH KOREA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 304 SOUTH KOREA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 305 SOUTH KOREA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 306 SOUTH KOREA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 307 SOUTH KOREA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 308 SOUTH KOREA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 309 SOUTH KOREA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 310 SOUTH KOREA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 311 SOUTH KOREA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 312 SOUTH KOREA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 313 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 314 AUSTRALIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 315 AUSTRALIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 316 AUSTRALIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 317 AUSTRALIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 318 AUSTRALIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 319 AUSTRALIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 320 AUSTRALIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 321 AUSTRALIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 322 AUSTRALIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 323 AUSTRALIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 324 AUSTRALIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 325 AUSTRALIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 326 AUSTRALIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 327 INDIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 328 INDIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 329 INDIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 330 INDIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 331 INDIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 332 INDIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 333 INDIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 334 INDIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 335 INDIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 336 INDIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 337 INDIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 338 INDIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 339 INDIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 340 INDIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 341 SINGAPORE PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 342 SINGAPORE PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 343 SINGAPORE MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 344 SINGAPORE RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 345 SINGAPORE PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 346 SINGAPORE GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 347 SINGAPORE GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 348 SINGAPORE LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 349 SINGAPORE HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 350 SINGAPORE UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 351 SINGAPORE PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 352 SINGAPORE BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 353 SINGAPORE PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 354 SINGAPORE PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 355 INDONESIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 356 INDONESIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 357 INDONESIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 358 INDONESIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 359 INDONESIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 360 INDONESIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 361 INDONESIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 362 INDONESIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 363 INDONESIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 364 INDONESIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 365 INDONESIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 366 INDONESIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 367 INDONESIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 368 INDONESIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 369 MALAYSIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 370 MALAYSIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 371 MALAYSIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 372 MALAYSIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 373 MALAYSIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 374 MALAYSIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 375 MALAYSIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 376 MALAYSIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 377 MALAYSIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 378 MALAYSIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 379 MALAYSIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 380 MALAYSIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 381 MALAYSIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 382 MALAYSIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 383 THAILAND PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 384 THAILAND PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 385 THAILAND MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 386 THAILAND RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 387 THAILAND PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 388 THAILAND GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 389 THAILAND GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 390 THAILAND LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 391 THAILAND HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 392 THAILAND UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 393 THAILAND PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 394 THAILAND BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 395 THAILAND PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 396 THAILAND PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 397 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 398 PHILIPPINES PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 399 PHILIPPINES MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 400 PHILIPPINES RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 401 PHILIPPINES PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 402 PHILIPPINES GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 403 PHILIPPINES GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 404 PHILIPPINES LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 405 PHILIPPINES HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 406 PHILIPPINES UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 407 PHILIPPINES PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 408 PHILIPPINES BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 409 PHILIPPINES PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 410 PHILIPPINES PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 411 REST OF ASIA-PACIFIC PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 412 REST OF ASIA-PACIFIC PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 413 SOUTH AMERICA PDX MODELS MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 414 SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 415 SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 416 SOUTH AMERICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 417 SOUTH AMERICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 418 SOUTH AMERICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 419 SOUTH AMERICA GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 420 SOUTH AMERICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 421 SOUTH AMERICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 422 SOUTH AMERICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 423 SOUTH AMERICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 424 SOUTH AMERICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 425 SOUTH AMERICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 426 SOUTH AMERICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 427 SOUTH AMERICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 428 BRAZIL PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 429 BRAZIL PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 430 BRAZIL MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 431 BRAZIL RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 432 BRAZIL PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 433 BRAZIL GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 434 BRAZIL GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 435 BRAZIL LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 436 BRAZIL HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 437 BRAZIL UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 438 BRAZIL PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 439 BRAZIL BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 440 BRAZIL PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 441 BRAZIL PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 442 ARGENTINA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 443 ARGENTINA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 444 ARGENTINA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 445 ARGENTINA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 446 ARGENTINA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 447 ARGENTINA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 448 ARGENTINA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 449 ARGENTINA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 450 ARGENTINA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 451 ARGENTINA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 452 ARGENTINA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 453 ARGENTINA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 454 ARGENTINA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 455 ARGENTINA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 456 REST OF SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 457 REST OF SOUTH AMERICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 458 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY COUNTRY, 2018-2027 (USD THOUSAND)
  • TABLE 459 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 460 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 461 MIDDLE EAST & AFRICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 462 MIDDLE EAST & AFRICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 463 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 464 MIDDLE EAST & AFRICA GASTROINTESTINAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 465 MIDDLE EAST & AFRICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 466 MIDDLE EAST & AFRICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 467 MIDDLE EAST & AFRICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 468 MIDDLE EAST & AFRICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 469 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 470 MIDDLE EAST & AFRICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 471 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 472 MIDDLE EAST & AFRICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 473 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 474 SOUTH AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 475 SOUTH AFRICA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 476 SOUTH AFRICA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 477 SOUTH AFRICA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 478 SOUTH AFRICA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 479 SOUTH AFRICA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 480 SOUTH AFRICA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 481 SOUTH AFRICA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 482 SOUTH AFRICA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 483 SOUTH AFRICA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 484 SOUTH AFRICA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 485 SOUTH AFRICA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 486 SOUTH AFRICA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 487 U.A.E. PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 488 U.A.E. PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 489 U.A.E. MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 490 U.A.E. RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 491 U.A.E. PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 492 U.A.E. GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 493 U.A.E. GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 494 U.A.E. LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 495 U.A.E. HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 496 U.A.E. UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 497 U.A.E. PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 498 U.A.E. BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 499 U.A.E. PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 500 U.A.E. PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 501 ISRAEL PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 502 ISRAEL PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 503 ISRAEL MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 504 ISRAEL RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 505 ISRAEL PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 506 ISRAEL GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 507 ISRAEL GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 508 ISRAEL LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 509 ISRAEL HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 510 ISRAEL UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 511 ISRAEL PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 512 ISRAEL BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 513 ISRAEL PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 514 ISRAEL PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 515 SAUDI ARABIA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 516 SAUDI ARABIA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 517 SAUDI ARABIA MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 518 SAUDI ARABIA RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 519 SAUDI ARABIA PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 520 SAUDI ARABIA GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 521 SAUDI ARABIA GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 522 SAUDI ARABIA LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 523 SAUDI ARABIA HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 524 SAUDI ARABIA UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 525 SAUDI ARABIA PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 526 SAUDI ARABIA BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 527 SAUDI ARABIA PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 528 SAUDI ARABIA PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 529 EGYPT PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 530 EGYPT PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)
  • TABLE 531 EGYPT MICE MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 532 EGYPT RAT MODELS IN PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 533 EGYPT PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 534 EGYPT GASTROINTESTINAL MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 535 EGYPT GYNECOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 536 EGYPT LUNG TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 537 EGYPT HEMATOLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 538 EGYPT UROLOGICAL TUMOR MODELS IN PDX MODELS MARKET, BY TUMOR TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 539 EGYPT PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 540 EGYPT BASIC CANCER RESEARCH IN PDX MODELS MARKET, BY APPLICATION, 2018-2027 (USD THOUSAND)
  • TABLE 541 EGYPT PDX MODELS MARKET, BY TECHNIQUE, 2018-2027 (USD THOUSAND)
  • TABLE 542 EGYPT PDX MODELS MARKET, BY END USER, 2018-2027 (USD THOUSAND)
  • TABLE 543 REST OF MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (USD THOUSAND)
  • TABLE 544 REST OF MIDDLE EAST & AFRICA PDX MODELS MARKET, BY TYPE, 2018-2027 (UNITS)

LIST OF FIGURES

  • FIGURE 1 GLOBAL PDX MODELS MARKET: SEGMENTATION 43
  • FIGURE 2 GLOBAL PDX MODELS MARKET : DATA TRIANGULATION 46
  • FIGURE 3 GLOBAL PDX MODELS MARKET : DROC ANALYSIS 47
  • FIGURE 4 GOBAL PDX MODELS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS 48
  • FIGURE 5 GLOBAL PDX MODELS MARKET: COMPANY RESEARCH ANALYSIS 48
  • FIGURE 6 GLOBAL PDX MODELS MARKET : INTERVIEW DEMOGRAPHICS 51
  • FIGURE 7 GLOBAL PDX MODELS MARKET: DBMR MARKET POSITION GRID 52
  • FIGURE 8 GLOBAL PDX MODELS MARKET: VENDOR SHARE ANALYSIS 53
  • FIGURE 9 GLOBAL PDX MODELS MARKET: APPLICATION GRID 54
  • FIGURE 10 GLOBAL PDX MODELS MARKET: SEGMENTATION 57
  • FIGURE 11 WIDE ADOPTION OF PDX MODELS IN PRE-CLINICAL RESEARCH WITH INCREASING DEMAND FOR PERSONALIZED MEDICINE IS EXPECTED TO DRIVE THE GLOBAL PDX MODELS MARKET IN THE FORECAST PERIOD OF 2020 TO 2027 58
  • FIGURE 12 MICE MODELS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PDX MODELS MARKET IN 2020 & 2027 58
  • FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL PDX MODELS MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2020 TO 2027 59
  • FIGURE 14 NORTH AMERICA IS THE FASTEST GROWING MARKET FOR GLOBAL PDX MODELS MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027 60
  • FIGURE 15 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGE OF GLOBAL PDX MODELS MARKET 63
  • FIGURE 16 BREAKDOWN OF ONCOLOGY TRIALS OVER THE LAST FIVE YEARS 67
  • FIGURE 17 EXPANSION OF R&D IN PHARMACEUTICAL COMPANIES AS A PROPORTION OF GDP 69
  • FIGURE 18 GLOBAL PDX MODELS MARKET: BY TYPE, 2019 76
  • FIGURE 19 GLOBAL PDX MODELS MARKET: BY TYPE, 2019-2027 (USD THOUSAND) 77
  • FIGURE 20 GLOBAL PDX MODELS MARKET: BY TYPE, CAGR (2020-2027) 77
  • FIGURE 21 GLOBAL PDX MODELS MARKET: BY TYPE, LIFELINE CURVE 78
  • FIGURE 22 GLOBAL PDX MODELS MARKET: BY TUMOR TYPE, 2019 84
  • FIGURE 23 GLOBAL PDX MODELS MARKET: BY TUMOR TYPE, 2019-2027 (USD THOUSAND) 85
  • FIGURE 24 GLOBAL PDX MODELS MARKET: BY TUMOR TYPE, CAGR (2020-2027) 85
  • FIGURE 25 GLOBAL PDX MODELS MARKET: BY TUMOR TYPE, LIFELINE CURVE 86
  • FIGURE 26 GLOBAL PDX MODELS MARKET: BY APPLICATION, 2019 97
  • FIGURE 27 GLOBAL PDX MODELS MARKET: BY APPLICATION, 2019-2027 (USD THOUSAND) 98
  • FIGURE 28 GLOBAL PDX MODELS MARKET: BY APPLICATION, CAGR (2020-2027) 98
  • FIGURE 29 GLOBAL PDX MODELS MARKET: BY APPLICATION, LIFELINE CURVE 99
  • FIGURE 30 GLOBAL PDX MODELS MARKET: BY TECHNIQUE, 2019 105
  • FIGURE 31 GLOBAL PDX MODELS MARKET: BY TECHNIQUE, 2019-2027 (USD THOUSAND) 106
  • FIGURE 32 GLOBAL PDX MODELS MARKET: BY TECHNIQUE, CAGR (2020-2027) 106
  • FIGURE 33 GLOBAL PDX MODELS MARKET: BY TECHNIQUE, LIFELINE CURVE 107
  • FIGURE 34 GLOBAL PDX MODELS MARKET: BY END USER, 2019 110
  • FIGURE 35 GLOBAL PDX MODELS MARKET: BY END USER, 2019-2027 (USD THOUSAND) 111
  • FIGURE 36 GLOBAL PDX MODELS MARKET: BY END USER, CAGR (2020-2027) 111
  • FIGURE 37 GLOBAL PDX MODELS MARKET: BY END USER, LIFELINE CURVE 112
  • FIGURE 38 GLOBAL PDX MODELS MARKET: SNAPSHOT (2019) 118
  • FIGURE 39 GLOBAL PDX MODELS MARKET: BY REGION (2019) 119
  • FIGURE 40 GLOBAL PDX MODELS MARKET: BY REGION (2020 & 2027) 119
  • FIGURE 41 GLOBAL PDX MODELS MARKET: BY REGION (2019 & 2027) 120
  • FIGURE 42 GLOBAL PDX MODELS MARKET: BY TYPE (2020-2027) 120
  • FIGURE 43 NORTH AMERICA PDX MODELS MARKET: SNAPSHOT (2019) 122
  • FIGURE 44 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2019) 123
  • FIGURE 45 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2020 & 2027) 123
  • FIGURE 46 NORTH AMERICA PDX MODELS MARKET: BY COUNTRY (2019 & 2027) 124
  • FIGURE 47 NORTH AMERICA PDX MODELS MARKET: BY TYPE (2020-2027) 124
  • FIGURE 48 EUROPE PDX MODELS MARKET: SNAPSHOT (2019) 141
  • FIGURE 49 EUROPE PDX MODELS MARKET: BY COUNTRY (2019) 142
  • FIGURE 50 EUROPE PDX MODELS MARKET: BY COUNTRY (2020 & 2027) 142
  • FIGURE 51 EUROPE PDX MODELS MARKET: BY COUNTRY (2019 & 2027) 143
  • FIGURE 52 EUROPE PDX MODELS MARKET: BY TYPE (2020-2027) 143
  • FIGURE 53 ASIA-PACIFIC PDX MODELS MARKET: SNAPSHOT (2019) 190
  • FIGURE 54 ASIA-PACIFIC PDX MODELS MARKET: BY COUNTRY (2019) 191
  • FIGURE 55 ASIA-PACIFIC PDX MODELS MARKET: BY COUNTRY (2020 & 2027) 191
  • FIGURE 56 ASIA-PACIFIC PDX MODELS MARKET: BY COUNTRY (2019 & 2027) 192
  • FIGURE 57 ASIA-PACIFIC PDX MODELS MARKET: BY TYPE (2020-2027) 192
  • FIGURE 58 SOUTH AMERICA PDX MODELS MARKET: SNAPSHOT (2019) 239
  • FIGURE 59 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2019) 240
  • FIGURE 60 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2020 & 2027) 240
  • FIGURE 61 SOUTH AMERICA PDX MODELS MARKET: BY COUNTRY (2019 & 2027) 241
  • FIGURE 62 SOUTH AMERICA PDX MODELS MARKET: BY TYPE (2020-2027) 241
  • FIGURE 63 MIDDLE EAST & AFRICA PDX MODELS MARKET: SNAPSHOT (2019) 255
  • FIGURE 64 MIDDLE EAST & AFRICA PDX MODELS MARKET: BY COUNTRY (2019) 256
  • FIGURE 65 MIDDLE EAST & AFRICA PDX MODELS MARKET: BY COUNTRY (2020 & 2027) 256
  • FIGURE 66 MIDDLE EAST & AFRICA PDX MODELS MARKET: BY COUNTRY (2019 & 2027) 257
  • FIGURE 67 MIDDLE EAST & AFRICA PDX MODELS MARKET: BY TYPE (2020-2027) 257
  • FIGURE 68 GLOBAL PDX MODELS MARKET: COMPANY SHARE 2019 (%) 283
  • FIGURE 69 NORTH AMERICA PDX MODELS MARKET: COMPANY SHARE 2019 (%) 284
  • FIGURE 70 EUROPE PDX MODELS MARKET: COMPANY SHARE 2019 (%) 285
  • FIGURE 71 ASIA-PACIFIC PDX MODELS MARKET: COMPANY SHARE 2019 (%) 286
目次

Global PDX models market is projected to register a healthy CAGR of 16.6% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027

Market Segmentation

Global PDX Models Market, By Type (Mice Models and Rat Models), Tumor Type (Gastrointestinal Tumor Models, Gynecological Tumor Models, Respiratory Tumor Models, Lung Tumor Models, Urological Tumor Models, Hematological Tumor Models and Others), Application (Preclinical Drug Development, Precision Medicine, Co-clinical Trials, Basic Cancer Research & Biomarker Analysis), Technique (Heterotopic Implantation and Orthotropic Implantation), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Academic & Research Organizations and Others), Country (U.S., Canada, Mexico, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Rest of Europe, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends & Forecast to 2027

Some of the major factors contributing to the growth of the global PDX models market are:

Wide adoption of PDX models in preclinical research

Increase in demand of personalized medicine

Strategic initiative by government and private organizations

Market Players

The key market players for global PDX models market are listed below:

Crown Bioscience Inc.

THE JACKSON LABORATORY

Champions Oncology, Inc.

Charles River Laboratories

Wuxi AppTec

Oncodesign

Aragen Bioscience

Biocytogen

Bioduro

BioModels

Creative Animodel

Covance Inc.

EPO Berlin-Buch GmbH

EUROPDX.

Explora Biolabs

Hera BioLabs

Horizon discovery Ltd.

Pharmatest Services

Urosphere SAS

Xentech

Xenopat

TABLE OF CONTENTS

1 INTRODUCTION 37

  • 1.1 OBJECTIVES OF THE STUDY 37
  • 1.2 MARKET DEFINITION 37
  • 1.3 OVERVIEW OF GLOBAL PDX MODELS MARKET 38
  • 1.4 CURRENCY AND PRICING 39
  • 1.5 LIMITATIONS 39
  • 1.6 MARKETS COVERED 40

2 MARKET SEGMENTATION 43

  • 2.1 MARKETS COVERED 43
  • 2.2 GEOGRAPHICAL SCOPE 44
  • 2.3 YEARS CONSIDERED FOR THE STUDY 45
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL 46
  • 2.5 MULTIVARIATE MODELLING 49
  • 2.6 LIFELINE CURVE BY TYPE 50
  • 2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 51
  • 2.8 DBMR MARKET POSITION GRID 52
  • 2.9 VENDOR SHARE ANALYSIS 53
  • 2.10 APPLICATION GRID 54
  • 2.11 SECONDARY SOURCES 55
  • 2.12 ASSUMPTIONS 55

3 EXECUTIVE SUMMARY 56

4 PREMIUM INSIGHTS 58

  • 4.1 POTENTIAL ALTERNATIVE APPROACHES AND REPLACEMENT ANALYSIS 61

5 MARKET OVERVIEW 62

  • 5.1 DRIVERS 64
    • 5.1.1 WIDE ADOPTION OF PDX MODELS IN PRE-CLINICAL RESEARCH 64
    • 5.1.2 INCREASING DEMAND FOR PERSONALIZED MEDICINE 65
    • 5.1.3 RISING DEMAND FOR HUMANIZED PDX MODELS 65
    • 5.1.4 GROWTH IN CONTRACT RESEARCH ORGANIZATIONS (CROS) AND ACADEMIC AND RESEARCH INSTITUTIONS FOR CANCER RESEARCH 66
  • 5.2 RESTRAINTS 67
    • 5.2.1 ETHICAL ISSUES REGARDING USAGE OF ANIMALS 67
    • 5.2.2 HIGH COST OF CUSTOMIZED PDX MODELS 68

  • 5.3 OPPORTUNITIES 69
    • 5.3.1 INCREASE IN R&D ACTIVITIES IN THE PHARMACEUTICAL INDUSTRIES 69
    • 5.3.2 STRATEGIC INITIATIVES BY GOVERNMENT & PRIVATE SECTORS 69
  • 5.4 CHALLENGES 71
    • 5.4.1 STRINGENT GUIDELINES FOR THE USE OF ANIMAL MODELS IN CANCER RESEARCH 71
    • 5.4.2 LIMITATIONS OF PDX MODELS 72

6 SARS-COV-2 PANDEMIC IMPACT ANALYSIS 73

7 GLOBAL PDX MODELS MARKET, BY TYPE 75

  • 7.1 OVERVIEW 76
  • 7.2 MICE MODELS 79
    • 7.2.1 BASIC CANCER RESEARCH 80
    • 7.2.2 PRECLINICAL DRUG DEVELOPMENT 80
    • 7.2.3 BIOMARKER ANALYSIS 80
    • 7.2.4 CO-CLINICAL TRIALS 80
    • 7.2.5 PRECISION MEDICINE 80
  • 7.3 RAT MODELS 80
    • 7.3.1 BASIC CANCER RESEARCH 81
    • 7.3.2 PRECLINICAL DRUG DEVELOPMENT 81
    • 7.3.3 BIOMARKER ANALYSIS 82
    • 7.3.4 CO-CLINICAL TRIALS 82
    • 7.3.5 PRECISION MEDICINE 82

8 GLOBAL PDX MODELS MARKET, BY TUMOR TYPE 83

  • 8.1 OVERVIEW 84
  • 8.2 GASTROINTESTINAL TUMOR MODELS 87
    • 8.2.1 COLORECTAL TUMOR 88
    • 8.2.2 PANCREATIC TUMOR 88
    • 8.2.3 HEPATIC TUMOR 88
    • 8.2.4 OTHERS 88
  • 8.3 LUNG TUMOR MODELS 88
    • 8.3.1 SQUAMOUS CELL CARCINOMA 89
    • 8.3.2 LARGE CELL CARCINOMA 89
    • 8.3.3 ADENOCARCINOMA 89
    • 8.3.4 BRONCHIAL TUMOR 89
  • 8.4 HEMATOLOGICAL TUMOR MODELS 90
    • 8.4.1 LYMPHOMA 90
    • 8.4.2 LEUKEMIA 91

  • 8.5 GYNECOLOGICAL TUMOR MODELS 91
    • 8.5.1 OVARIAN TUMOR 92
    • 8.5.2 BREAST TUMOR 92
    • 8.5.3 CERVICAL TUMOR 92
  • 8.6 RESPIRATORY TUMOR MODELS 92
  • 8.7 UROLOGICAL TUMOR MODELS 93
    • 8.7.1 BLADDER TUMOR 94
    • 8.7.2 PROSTATE TUMOR 94
    • 8.7.3 RENAL TUMOR 94
  • 8.8 OTHERS 95

9 GLOBAL PDX MODELS MARKET, BY APPLICATION 96

  • 9.1 OVERVIEW 97
  • 9.2 BASIC CANCER RESEARCH 100
    • 9.2.1 CHARCTERIZATION OF CANCER BIOLOGY 101
    • 9.2.2 TUMORIGENISIS 101
    • 9.2.3 METASTATIS 101
  • 9.3 PRECLINICAL DRUG DEVELOPMENT 101
  • 9.4 BIOMARKER ANALYSIS 102
  • 9.5 CO-CLINICAL TRIALS 102
  • 9.6 PRECISION MEDICINE 103

10 GLOBAL PDX MODELS MARKET, BY TECHNIQUE 104

  • 10.1 OVERVIEW 105
  • 10.2 HETEROTOPIC IMPLANTATION 107
  • 10.3 ORTHOTOPIC IMPLANTATION 108

11 GLOBAL PDX MODELS MARKET, BY END USER 109

  • 11.1 OVERVIEW 110
  • 11.2 ACADEMIC AND RESEARCH INSTITUTIONS 113
  • 11.3 CONTRACT RESEARCH ORGANIZATIONS 113
  • 11.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES 114
  • 11.5 OTHERS 115

12 GLOBAL PDX MODELS MARKET, BY GEOGRAPHY 116

  • 12.1 OVERVIEW 117
  • 12.2 NORTH AMERICA 122
    • 12.2.1 U.S. 129
    • 12.2.2 CANADA 133
    • 12.2.3 MEXICO 137

  • 12.3 EUROPE 141
    • 12.3.1 GERMANY 149
    • 12.3.2 FRANCE 153
    • 12.3.3 U.K. 157
    • 12.3.4 ITALY 161
    • 12.3.5 SPAIN 165
    • 12.3.6 SWITZERLAND 169
    • 12.3.7 NETHERLANDS 173
    • 12.3.8 BELGIUM 177
    • 12.3.9 RUSSIA 181
    • 12.3.10 TURKEY 185
    • 12.3.11 REST OF EUROPE 189
  • 12.4 ASIA-PACIFIC 190
    • 12.4.1 CHINA 198
    • 12.4.2 JAPAN 202
    • 12.4.3 SOUTH KOREA 206
    • 12.4.4 AUSTRALIA 210
    • 12.4.5 INDIA 214
    • 12.4.6 SINGAPORE 218
    • 12.4.7 INDONESIA 222
    • 12.4.8 MALAYSIA 226
    • 12.4.9 THAILAND 230
    • 12.4.10 PHILIPPINES 234
    • 12.4.11 REST OF ASIA-PACIFIC 238
  • 12.5 SOUTH AMERICA 239
    • 12.5.1 BRAZIL 246
    • 12.5.2 ARGENTINA 250
    • 12.5.3 REST OF SOUTH AMERICA 254
  • 12.6 MIDDLE EAST & AFRICA 255
    • 12.6.1 SOUTH AFRICA 262
    • 12.6.2 U.A.E. 266
    • 12.6.3 ISRAEL 270
    • 12.6.4 SAUDI ARABIA 274
    • 12.6.5 EGYPT 278
    • 12.6.6 REST OF MIDDLE EAST & AFRICA 282

13 GLOBAL PDX MODELS MARKET, COMPANY LANDSCAPE 283

  • 13.1 COMPANY SHARE ANALYSIS: GLOBAL 283
  • 13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 284
  • 13.3 COMPANY SHARE ANALYSIS: EUROPE 285
  • 13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 286

14 SWOT ANALYSIS: GLOBAL PDX MODELS MARKET 287

  • 14.1 SWOT ANALYSIS 287
    • 14.1.1 STRENGTH: - WIDE PRODUCT PORTFOLIO 287
    • 14.1.2 STRENGTH: - EXTENSIVE RESEARCH AND DEVELOPMENT ACTIVITIES 287
    • 14.1.3 WEAKNESS: - HIGH COST 288
    • 14.1.4 OPPORTUNITY: - EXPANDING BUSINESS THOROUGH THEIR SUBSIDIARIES 288
    • 14.1.5 OPPORTUNITY: - STRATEGIC INITIATIVE ESPECIALLY COLLABORATION 289
    • 14.1.6 THREAT: - STRINGENT GUIDELINES FOR THE USE OF ANIMAL MODELS IN CANCER RESEARCH 289
  • 14.2 DATA BRIDGE MARKET RESEARCH ANALYSIS: GLOBAL PDX MODELS MARKET 290

15 COMPANY PROFILES 291

  • 15.1 CROWN BIOSCIENCE INC. 291
    • 15.1.1 COMPANY SNAPSHOT 291
    • 15.1.2 COMPANY SHARE ANALYSIS 291
    • 15.1.3 PRODUCT PORTFOLIO 292
    • 15.1.4 RECENT DEVELOPMENTS 292
  • 15.2 THE JACKSON LABORATORY 293
    • 15.2.1 COMPANY SNAPSHOT 293
    • 15.2.2 COMPANY SHARE ANALYSIS 293
    • 15.2.3 PRODUCT PORTFOLIO 294
    • 15.2.4 RECENT DEVELOPMENT 294
  • 15.3 CHAMPIONS ONCOLOGY, INC. 295
    • 15.3.1 COMPANY SNAPSHOT 295
    • 15.3.2 COMPANY SHARE ANALYSIS 295
    • 15.3.3 PRODUCT PORTFOLIO 296
    • 15.3.4 RECENT DEVELOPMENTS 296
  • 15.4 CHARLES RIVER LABORATORIES 297
    • 15.4.1 COMPANY SNAPSHOT 297
    • 15.4.2 REVENUE ANALYSIS 298
    • 15.4.3 COMPANY SHARE ANALYSIS 298
    • 15.4.4 PRODUCT PORTFOLIO 299
    • 15.4.5 RECENT DEVELOPMENTS 299
  • 15.5 WUXI APPTEC 300
    • 15.5.1 COMPANY SNAPSHOT 300
    • 15.5.2 REVENUE ANALYSIS 301
    • 15.5.3 COMPANY SHARE ANALYSIS 301
    • 15.5.4 PRODUCT PORTFOLIO 302
    • 15.5.5 RECENT DEVELOPMENT 302
  • 15.6 ONCODESIGN 303
    • 15.6.1 COMPANY SNAPSHOT 303
    • 15.6.2 REVENUE ANALYSIS 303
    • 15.6.3 TECHNOLOGY PORTFOLIO 304
    • 15.6.4 RECENT DEVELOPMENT 304
  • 15.7 ARAGEN BIOSCIENCE 305
    • 15.7.1 COMPANY SNAPSHOT 305
    • 15.7.2 PRODUCT PORTFOLIO 305
    • 15.7.3 RECENT DEVELOPMENT 305
  • 15.8 BIOCYTOGEN 306
    • 15.8.1 COMPANY SNAPSHOT 306
    • 15.8.2 PRODUCT PORTFOLIO 306
    • 15.8.3 RECENT DEVELOPMENT 306
  • 15.9 BIODURO 307
    • 15.9.1 COMPANY SNAPSHOT 307
    • 15.9.2 PRODUCT PORTFOLIO 307
    • 15.9.3 RECENT DEVELOPMENT 307
  • 15.10 BIOMODELS 308
    • 15.10.1 COMPANY SNAPSHOT 308
    • 15.10.2 PRODUCT PORTFOLIO 308
    • 15.10.3 RECENT DEVELOPMENT 308
  • 15.11 CREATIVE ANIMODEL 309
    • 15.11.1 COMPANY SNAPSHOT 309
    • 15.11.2 PRODUCT PORTFOLIO 309
    • 15.11.3 RECENT DEVELOPMENT 309
  • 15.12 COVANCE INC. 310
    • 15.12.1 COMPANY SNAPSHOT 310
    • 15.12.2 REVENUE ANALYSIS 311
    • 15.12.3 PRODUCT PORTFOLIO 311
    • 15.12.4 RECENT DEVELOPMENT 311
  • 15.13 EPO BERLIN-BUCH GMBH 312
    • 15.13.1 COMPANY SNAPSHOT 312
    • 15.13.2 PRODUCT PORTFOLIO 312
    • 15.13.3 RECENT DEVELOPMENT 313
  • 15.14 EUROPDX. 314
    • 15.14.1 COMPANY SNAPSHOT 314
    • 15.14.2 PRODUCT PORTFOLIO 314
    • 15.14.3 RECENT DEVELOPMENT 314

  • 15.15 EXPLORA BIOLABS 315
    • 15.15.1 COMPANY SNAPSHOT 315
    • 15.15.2 PRODUCT PORTFOLIO 315
    • 15.15.3 RECENT DEVELOPMENTS 316
  • 15.16 HERA BIOLABS 317
    • 15.16.1 COMPANY SNAPSHOT 317
    • 15.16.2 PRODUCT PORTFOLIO 317
    • 15.16.3 RECENT DEVELOPMENT 317
  • 15.17 HORIZON DISCOVERY LTD. 318
    • 15.17.1 COMPANY SNAPSHOT 318
    • 15.17.2 REVENUE ANALYSIS 319
    • 15.17.3 PRODUCT PORTFOLIO 319
    • 15.17.4 RECENT DEVELOPMENTS 320
  • 15.18 PHARMATEST SERVICES 321
    • 15.18.1 COMPANY SNAPSHOT 321
    • 15.18.2 PRODUCT PORTFOLIO 321
    • 15.18.3 RECENT DEVELOPMENTS 322
  • 15.19 UROSPHERE SAS 323
    • 15.19.1 COMPANY SNAPSHOT 323
    • 15.19.2 PRODUCT PORTFOLIO 323
    • 15.19.3 RECENT DEVELOPMENT 323
  • 15.20 XENTECH 324
    • 15.20.1 COMPANY SNAPSHOT 324
    • 15.20.2 PRODUCT PORTFOLIO 324
    • 15.20.3 RECENT DEVELOPMENT 324
  • 15.21 XENOPAT 325
    • 15.21.1 COMPANY SNAPSHOT 325
    • 15.21.2 PRODUCT PORTFOLIO 325
    • 15.21.3 RECENT DEVELOPMENT 325

16 QUESTIONNAIRE 326

17 RELATED REPORTS 328